• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX25REC W/RES; BLOOD GAS OXYGENATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX25REC W/RES; BLOOD GAS OXYGENATOR Back to Search Results
Model Number 3CX*FX25REC
Device Problem Particulates (1451)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/29/2018
Event Type  malfunction  
Manufacturer Narrative
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.For this reason, terumo references evaluation conclusion code.No known impact or consequence to patient.Particulates.Results pending completion of evaluation.Conclusion not yet available-evaluation in progress.
 
Event Description
The user facility reported to terumo cardiovascular that after cardiopulmonary bypass, particulates were seen upon flushing the reservoir and circuit with saline.No known impact or consequence to patient.
 
Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on march 05, 2018.(b)(4).The actual sample was not returned but the provided pictures were reviewed.Some fatty tissues were noticed inside the reservoir.Without the returned device, a thorough investigation cannot be performed.The retention sample from the same product code/lot number was used for the blood clotting test.Bovine blood was ran through the venous reservoir for an hour at 7l/min, at the end of the test the sample was rinsed and dried; a visual inspection confirmed no clotting or residues with the reservoir.The reported event was unable to be replicated; therefore, a definitive root cause was not able to be determined.It is likely that patient conditions contributed to the formations of fatty tissue or biological material within the reservoir.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STERILE FX25REC W/RES
Type of Device
BLOOD GAS OXYGENATOR
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
125 blue ball road
elkton MD 21921
MDR Report Key7313776
MDR Text Key101693003
Report Number1124841-2018-00035
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
PMA/PMN Number
K151791
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Type of Report Initial,Followup
Report Date 04/13/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/05/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2020
Device Model Number3CX*FX25REC
Device Catalogue NumberN/A
Device Lot NumberVM16
Other Device ID Number(01)00699753450820
Was Device Available for Evaluation? No
Date Manufacturer Received04/12/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-